# Whipple's Disease and Interleukins

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/whipple-s-disease-and-interleukins/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the pathogenesis, diagnosis, and treatment of Whipple's disease, caused by the bacterium Tropheryma whipplei. It covers topics such as bacterial cultivation, genome sequencing, interleukin-16 involvement, central nervous system manifestations, PCR diagnosis, microbial susceptibility to antibiotics, and the immune reconstitution inflammatory syndrome. The research also delves into the association of Whipple's disease with immunosuppressive therapy and explores potential genetic biomarkers for disease susceptibility. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t13834 |
| Works | 37 |

## Topic papers all

Showing 15 of 37.

- [The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation](https://scholariq.org/papers/the-biological-functions-of-t-helper-17-cell-effector-cytokines-in-inflammation/)
- [Vitamin D and the Immune System](https://scholariq.org/papers/vitamin-d-and-the-immune-system/)
- [A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity](https://scholariq.org/papers/a-human-natural-killer-cell-subset-provides-an-innate-source-of-il-22-for/)
- [STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing](https://scholariq.org/papers/stat3-links-il-22-signaling-in-intestinal-epithelial-cells-to-mucosal-wound/)
- [Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity](https://scholariq.org/papers/intestinal-microbiota-derived-short-chain-fatty-acids-regulation-of-immune-cell/)
- [The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease](https://scholariq.org/papers/the-role-of-endomyocardial-biopsy-in-the-management-of-cardiovascular-disease-2/)
- [Gain-of-function human <i>STAT1</i> mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis](https://scholariq.org/papers/gain-of-function-human-i-stat1-i-mutations-impair-il-17-immunity-and-underlie/)
- [Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis](https://scholariq.org/papers/anti-il-23-therapy-inhibits-multiple-inflammatory-pathways-and-ameliorates/)
- [Single base polymorphism at −511 in the human interleukin-1β gene (IL1β)](https://scholariq.org/papers/single-base-polymorphism-at-511-in-the-human-interleukin-1-gene-il1/)
- [Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice](https://scholariq.org/papers/inhibition-of-il-17a-attenuates-atherosclerotic-lesion-development-in-apoe/)
- [Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document](https://scholariq.org/papers/recommendations-for-initiation-and-cessation-of-enzyme-replacement-therapy-in/)
- [Inflammatory neuropathies of the enteric nervous system☆](https://scholariq.org/papers/inflammatory-neuropathies-of-the-enteric-nervous-system/)
- [Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-safety-and-immunogenicity-of-an-oral-recombinant-helicobacter-pylori/)
- [Novel concepts in the pathophysiology and treatment of functional dyspepsia](https://scholariq.org/papers/novel-concepts-in-the-pathophysiology-and-treatment-of-functional-dyspepsia/)
- [Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial](https://scholariq.org/papers/safety-and-efficacy-of-avalglucosidase-alfa-versus-alglucosidase-alfa-in/)

## Topic primary papers

- [Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis](https://scholariq.org/papers/anti-il-23-therapy-inhibits-multiple-inflammatory-pathways-and-ameliorates/)
- [When it’s not RA: unmasking Whipple’s disease in seronegative, difficult-to-treat rheumatoid arthritis](https://scholariq.org/papers/when-it-s-not-ra-unmasking-whipple-s-disease-in-seronegative-difficult-to-treat/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.